Description :

According to a new market research report published by Transparency Market Research “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020” the global acute ischemic stroke diagnosis and treatment market was valued at USD 1.2 billion in 2013 and is estimated to reach a market worth of USD 1.9 billion in 2020 growing at a CAGR of 6.3% from 2014 to 2020.

Acute ischemic stroke is referred as loss of blood circulation by an artery to certain areas of the brain that results in corresponding loss of neurologic function to that part of the brain. Acute ischemic stroke caused due to thrombotic or embolic occlusion of cerebral artery and it is considered as a common type of stroke as compared with hemorrhagic stroke. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of diagnosis and surgical procedures in acute stroke treatment. Moreover, high success rate associated with surgical procedures and short recovery period after surgery are also significant reasons that are considered as a driving factor for this market. However, excessive usage of medication for the treatment of ischemia stroke is anticipated to hinder the global market growth of acute ischemic stroke. Companies operating in this market focus on investing in emerging economies of Asia-Pacific such as India, China, Japan and South Korea. These economies represent huge potential for various acute ischemic stroke diagnosis and treatment products due to rising healthcare expenditure and presence of large patient pool suffering from ischemic stroke.

Browse the full Acute Ischemic Stroke Diagnosis and Treatment Market Report at :
http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html

The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnostics type into CT, MRI, ultrasound, cerebral angiography, nuclear imaging and others. Due to its effective and efficient detection of various large and small lesions in our body CT is considered as the most popular choice for detection of acute ischemic stroke. Hence, CT has accounted for the largest market share of the global acute ischemic stroke diagnosis and treatment market in 2013. However, high cost of ischemic stroke diagnosis with CT and technological complexities associated with CT would restrict the global market demand of CT in acute ischemic stroke.

Get Free Sample Report Acute Ischemic Stroke Diagnosis and Treatment Market :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799

In addition, the global market for acute ischemic stroke diagnosis and treatment is segmented based on surgery types into carotid endarterectomy, angioplasty and endovascular mechanical thrombectony. Due to high success rate, easy availability and short treatment duration carotid endarterectomy is the most preferred treatment for acute ischemia. According to the National Center for Biotechnology Information (NCBI), in the U.S. approximately 180,000 surgical carotid endarterectomy procedures are performed annually. However, side effect such as restenosis (reblockage of artery), nerve injury and numbness associated with carotid endarterectomy procedure are some reasons due to which the global demand of this procedure might be restricted during the study period.

Browse the full Acute Ischemic Stroke Diagnosis and Treatment Market press release at :
http://www.transparencymarketresearch.com/pressrelease/acute-ischemic-stroke-treatment-market.htm

On the basis of geography, the acute ischemic stroke diagnosis and treatment market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for acute ischemic stroke primarily due to the increase in ischemic stroke surgeries and introduction of technologically advanced medical devices and products. For instance, American Heart Association stated that, stroke is considered as the third leading cause of death in developed nations of the world such as the U.S., Canada. Moreover, it has also stated that, there are around 795,000 patient diagnosed with stroke in the U.S. every year where 85% of the total cases were identified as acute ischemic stroke. The National Institute of Health (NIH) stated that, healthcare cost for the treatment of stroke exceeds USD 73 billion in the U.S. every year. However, stringent regulatory compliance imposed by the U.S. FDA pertaining to medical device treatment utilized for human purpose (stroke) is considered as a hurdle for the growth of this market in North America. Europe accounted for the second largest share in the global acute ischemic stroke diagnosis and treatment market in 2013. Large geriatric population base is one of the important factors driving the growth of acute ischemic stroke diagnosis and treatment market in this region. Asia-Pacific is expected to grow at the highest CAGR from 2014 to 2020, owing to rising awareness among people and presence of large number of potential population with ischemic stroke. Additionally, companies are expecting large revenue with sufficient market penetration from Asia-Pacific region and thereby focusing on increasing investments in this region. However, oral anticoagulation with vitamin K antagonists (VKAs) such as warfarin, has been widely utilized as gold standard therapy for long-term acute stroke prevention in Asian countries. Thus, the aforementioned factors pose threat to the growth of the Asia-Pacific acute ischemic stroke diagnosis and treatment market.

Major market players include Abbott Laboratories (TREK), Covidien plc (Solitaire), Johnson & Johnson (PRECISE Carotid Stent System), GE Healthcare (Vivid Cardiovascular Ultrasound), Siemens Healthcare (Somatom Dual Source CT) and Stryker Corporation (Trevo) and Hitachi, Ltd. (SCENARIA).

The global acute ischemic stroke diagnosis and treatment market is segmented as follows:

Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type

Computed Tomography

Magnetic Resonance Imaging

Ultrasound

Cerebral Angiography

Nuclear Imaging

Others

Acute Ischemic Stroke Diagnosis and Treatment Market, by Surgery Type

Carotid Endarterectomy

Angioplasty

Endovascular Mechanical Thrombectomy

Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World

About Us :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.